… techniques can be used, from fluorescence in situ hybridization and immunohistochemistry
to next generation sequencing … fusion testing presents more technical challenges than other …

… In conclusion, most advanced NSCLC patients are unresectable and are diagnosed with
small biopsies or cytology, both of which may have insufficient DNA for molecular analysis. This …

… NGS technologies and their clinical application in diagnosis, … for all advanced-stage lung
cancers; if these are negative, … The use of NGS technology in lung cancer tests has proven …

… Whereas long-read sequencing works on sequence detection either by synthesis or by …
in cancer pathogenesis and build on the cancer genomics database. Lung cancer biomarkers …

… a next-generation sequencing-based in vitro diagnostic test that uses RNA isolated from
formalin-fixed paraffin embedded (FFPE) tumor … in non-small-cell lung cancer: results of a 2-year …

… they are often driving diagnostic innovation at times when … sequencing in daily practice
is weak.18, 19, 20, 21 We identified two economic studies in non-small-cell lung cancer (NSCLC). …

… We sought to compare the performance of targeted next-generation sequencing (NGS) …
lung cancer is increasing and Asia accounts for over half of new lung cancer cases diagnosed …

… profiles have the greatest diagnostic potential value in lung cancer diagnosis, but their …
and next-generation sequencing (NGS) as a pre-step that provides the sequencing of the …

… Although only 10 ng of RNA were needed, the Oncomine Focus Assay (Thermo Fisher
Scientific) was the least adequate assay for our purposes, as seven targetable lung cancer fusion …

… Targets), and Foundation One CDx are FDA-approved next-generation sequencing (NGS)-based
platforms for molecular testing. Broader NGS-based assays can evaluate emerging …